{
  "response": {
    "text": "The clinical trial ID for the study \"MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study\" is NCT02138422.\n",
    "citations": [
      "https://tlcr.amegroups.org/article/view/71591/html"
    ]
  }
}